Related Experiment Video

Updated: Jun 13, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity

Iuliana Ristea Popescu1, Audrey Helleboid-Chapman, Anthony Lucas

  • 1University Lille Nord de France, Lille, France.

FEBS Letters
|May 8, 2010
PubMed

Insights

Farnesoid X receptor (FXR) is functional in human islets, regulating glucose homeostasis. FXR activation protects beta-cells from lipotoxicity and improves insulin secretion, offering potential therapeutic targets for diabetes.

Area of Science:

  • Endocrinology
  • Metabolic research

Background:

  • Farnesoid X receptor (FXR) is crucial for bile acid, lipid, and glucose metabolism, primarily in the liver and intestine.
  • Its role in pancreatic beta-cells, which regulate insulin secretion, is less understood.

Purpose of the Study:

  • To investigate the expression and function of FXR in human islets and beta-cell lines.
  • To determine the impact of FXR deficiency and activation on islet function and protection against lipotoxicity.

Main Methods:

  • Gene expression analysis to confirm FXR functionality in human islets and beta-cell lines.
  • Comparison of islet architecture, gene expression, and glucose-stimulated insulin secretion (GSIS) between FXR-/- and wild-type mice.
  • Assessment of FXR localization in islets of lean versus obese mice.
  • Evaluation of FXR activation's protective effects on human islets against lipotoxicity.

Main Results:

  • FXR is expressed and functional in human islets and beta-cell lines.
  • FXR exhibits differential localization (cytosolic vs. nuclear) in lean versus obese mouse islets.
  • FXR deficiency in mice alters islet-specific gene expression and impairs GSIS.
  • FXR activation protects human islets from lipotoxicity and enhances their secretory index.

Conclusions:

  • FXR plays a significant role in regulating beta-cell function and insulin secretion.
  • FXR activation demonstrates therapeutic potential for protecting islets against lipotoxicity and improving secretory function in metabolic diseases.

More Related Videos

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...